Cardiovascular risk reduction with periodontal treatment in patients on the waiting list for renal transplantation
Carregando...
Citações na Scopus
9
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Citação
CLINICAL TRANSPLANTATION, v.33, n.8, article ID e13658, 8p, 2019
Resumo
Background Cardiovascular mortality is increased in chronic kidney disease, a condition with a high prevalence of periodontal disease. Whether periodontitis treatment improves prognosis is unknown. Methods The effect of periodontal treatment on the incidence of cardiovascular events and death in 206 waitlist hemodialysis subjects was compared with that in 203 historical controls who did not undergo treatment. Patients were followed up for 24 months or until death or transplantation. Results The prevalence of moderate/severe periodontitis was 74%. Coronary artery disease correlated with the severity of periodontal disease (P = .02). Survival free of cardiovascular events (94% vs 83%, log-rank 0.009), coronary events (97% vs 89%, log-rank = 0.009), and cardiovascular death (96% vs 87%, log-rank = 0.037) was higher in the evaluated group. Death by any cause did not differ between groups. Multivariate analysis showed that treatment was associated with reduction in cardiovascular events (HR 0.43; 95% CI 0.22-0.87), coronary events (HR 0.31; 95% CI 0.12-0.83), and cardiovascular deaths (HR 0.43; 95% CI 0.19-0.98). Conclusion Periodontal treatment reduced the 24-month incidence of cardiovascular events and cardiovascular death, suggesting that periodontal treatment may improve cardiovascular outcomes. We suggest that periodontal screening and eventual treatment may be considered in patients with advanced renal disease.
Palavras-chave
cardiovascular disease, chronic kidney disease, coronary artery disease, hemodialysis, renal transplantation
Referências
- Ariyamuthu VK, 2013, CARDIORENAL MED, V3, P71, DOI 10.1159/000350046
- Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1
- Chen LP, 2011, AM J KIDNEY DIS, V57, P276, DOI 10.1053/j.ajkd.2010.09.016
- De Lima JJG, 2003, HYPERTENSION, V42, P263, DOI 10.1161/01.HYP.0000087889.60760.87
- DESTEFANO F, 1993, BRIT MED J, V306, P688, DOI 10.1136/bmj.306.6879.688
- Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15
- Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373
- Fisher MA, 2010, CURR OPIN NEPHROL HY, V19, P519, DOI 10.1097/MNH.0b013e32833eda38
- Friedewald VE, 2009, AM J CARDIOL, V104, P59, DOI 10.1016/j.amjcard.2009.05.002
- Humphrey LL, 2008, J GEN INTERN MED, V23, P2079, DOI 10.1007/s11606-008-0787-6
- Kendrick J, 2008, NAT CLIN PRACT NEPHR, V4, P672, DOI 10.1038/ncpneph0954
- Kshirsagar AV, 2009, KIDNEY INT, V75, P746, DOI 10.1038/ki.2008.660
- Lafon A, 2014, EUR J NEUROL, V21, P1155, DOI 10.1111/ene.12415
- Leng WD, 2015, INT J CARDIOL, V201, P469, DOI 10.1016/j.ijcard.2015.07.087
- Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706
- Lockhart PB, 2012, CIRCULATION, V125, P2520, DOI 10.1161/CIR.0b013e31825719f3
- Longenecker JC, 2002, J AM SOC NEPHROL, V13, P1918, DOI 10.1097/01.ASN.0000019641.41496.1E
- Offenbacher S, 2009, J PERIODONTOL, V80, P190, DOI [10.1902/jop.2009.080007, 10.1902/jop.2009.080007 ]
- Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264
- Peng CH, 2017, INTERNAL MED, V56, P1015, DOI 10.2169/internalmedicine.56.7322
- Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401
- Ryden L, 2016, CIRCULATION, V133, P576, DOI 10.1161/CIRCULATIONAHA.115.020324
- Sarnak MJ, 2003, HYPERTENSION, V42, P1050, DOI 10.1161/01.HYP.0000102971.85504.7c
- Stewart R, 2016, CIRCULATION, V133, P549, DOI 10.1161/CIRCULATIONAHA.115.020869
- Vedin O, 2016, EUR J PREV CARDIOL, V23, P839, DOI 10.1177/2047487315621978
- Yu YH, 2015, J CLIN PERIODONTOL, V42, P21, DOI 10.1111/jcpe.12335